Contact
Biography
PLEASE NOTE IF YOU ARE A PATIENT CONTACTING ME ABOUT CLINICAL MATTERS I WILL NOT BE ABLE TO REPLY VIA THE ABOVE EMAIL DUE TO DATA PROTECTION LAW. PLEASE CONTACT MY NHS SECRETARY.
Ben Ollivere is Professor of Orthopaedic Trauma Surgery at the University of Nottingham and Honorary Consultant Orthopaedic Trauma Surgeon and Major Trauma Surgeon at the Queens Medical Centre, Nottingham. He is currently the Associate Pro Vice Chancellor for Research and Knowledge Exchange in the Faculty of Medicine and Health Sciences. He is also head of department for Trauma, Orthopaedics and Sports Medicine.
He trained in Oxford and London as a medical student, then Cambridge for his higher surgical training and moved to Nottingham for fellowship then spending 4 years as a consultant prior to being appointed Clinical Associate Professor, followed by promotion to Professor 4 years later.
He has active grants and research interests in big data, clinical and basic science studies. Ongoing randomised controlled trials funded by Innovate UK, the NiHR HTA and RfPB programmes as chief investigator. He takes an active part in the ARUK Sports Centre hosted at University of Nottingham.
Expertise Summary
He has clinical expertise in non-union, bone infection, trauma and major injury along with treatment of complex fractures and the complications of these treatments. He has a particular interest in limb reconstruction and his expertiese lise particularly in the use of circular frames and hexapod fixators. He has tertiary referral practices in bone infection, non-union and chest injuries.
Teaching Summary
I am an associate fellow of the higher education academy. I convene a wilderness medicine module on the Sports and Exercise Medicine MSc at masters level.
I have an interest in undergraduate and post graduate eduction, leading the MDD CP3 at University of Nottingham school of medicine. I also teach orthopedics at an undergraduate and post graduate level.
Research Summary
Ben Ollivere is leading global researcher (SciVal top 1% of researchers 4 topics, top 5% 14 topics: 2022 FW citations 3.99, FW views 13.9). He exerts a major scientific influence on trauma injury and… read more
Recent Publications
OLLIVERE B, METCALFE D, PERRY DC and HADDAD FS, 2020. SEARCHeD: Supporting Evaluation, Analysis and Reporting of routinely Collected Healthcare Data. The bone & joint journal. 102-B(2), 145-147 MARSON BA, NG J, MYINT Y, GRINDLAY DJC and OLLIVERE BJ, 2019. Management of 'low-risk' ankle fractures in children: a systematic review. Annals of the Royal College of Surgeons of England. 101(8), 539-545 OLLIVERE BJ, MARSON BA and HADDAD FS, 2019. Getting the right answer: core outcome sets in orthopaedics. The bone & joint journal. 101-B(3), 233-235
Current Research
Ben Ollivere is leading global researcher (SciVal top 1% of researchers 4 topics, top 5% 14 topics: 2022 FW citations 3.99, FW views 13.9). He exerts a major scientific influence on trauma injury and recovery, specifically outcomes, interventions, and their underlying mechanisms. He holds a personal grant portfolio valued at £61.7M (£9.7M as Co-I) spanning discovery, experimental, translational and applied spectra. His industry collaborations have resulted in spinouts, grants and first in man studies.
His research is thematic and applied; targeting life-course inequalities, particularly in key subpopulations (PMID:36424690;32475240;34779791), focussed on frailty and recovery in hip fracture, chest wall injury and upper limb trauma. For example in chest trauma (afflicting 20% of those with major injury) he led on national guidelines, to standardised access to chest wall fixation. Substantial underpinning research (PMID:27482027;30418334;31353094;35638213) has defined outcome measures, optimised analgesia, increased efficacy andunderpinning biological mechanism. Mortality is reduced by over 70% (PMID:35638213) in those stabilised (10-fold improvement).
He has had significant innovation impact, e.g. 3 patents (WO2021142213A1; WO2021173931A1; WO2023091366A1) for surgical devices (benefitting 10,000+ annually). Whilst still a trainee surgeon he was first to identify risk factors for metallosis (PMID:19651828) informing the issue of MHRA safety notices (MDA/2012/036). During Covid-19 he led the MRC Panther programme (studying healthcare workers), briefed SAGE, and was an expert to the medical All Party Parliamentary Group. These outputs supported the introduction of the covid vaccination booster programme (PMID:34376569).
As Associate Faculty Pro Vice-Chancellor he has engaged in national research direction (NIHR Commissioning Board, Medical Schools Council Research Board and Royal College of Physicians Falls and Frailty Programme) and internationally (advisor Finland Research Council, UK-China Medical Alliance). In training and education as regional Health Education England academic programme designed assessment, mentorship and appraisal process (100 academic trainees annually).
His research excellence is recognised through his NIHR Senior Investigator award and 'theme lead' his 'theme lead' status with the 28M Nottingham Biomedical Research Centre.
Past Research
His current grant portfolio includes :
2024-28 National Institute for Health and Social Care Research (NIHR) Senior Investiagtor award
2023-25 Medical Research Council "Identifying and targeting modifiable inflammatory factors underlying higher risk of frailty in individuals experiencing deprivation" £408K Co-applicant and lead clinician
2023-28 National Institute for Health Research (NIHR) Health Technology Assessment programme: £2.2M FOREST Trial Chief Investigator
2022-24 National Institute for Health Research (NIHR) Health Technology Assessment programme: £320,000
'Operative RIb Fixation Trial (ORIF) Extension' Chief Investigator
2022-2027 NIHR Nottingham Biomedical Research Centre (BRC) Musculoskeletal, Surgery, Inflammation and Recovery Theme Total 27M COI - Role: Theme lead
2021-23 Commercial Grant (Smith & Nephew) £60K SmartTSF Chief Investigator
2021-24 British Orthopaedic Association CTU Infrastructure Grant £70k/PA
2021-24 NIHR EME Programme £520k (OPERA mechanistic study) Chief Investigator
2021-23 NIHR RfPB Programme £245k ESPEAR Co-Applicant and mentor to CI.
2021-23 Medial Research Council (Covid Rapid Response) £5.2M Co-Connect Co-Applicant (WP Lead)
2020-2022 Medical Research Council (Covid Rapid Response) £900k PANTHER study Co-Chief Investigator
2020-2021 National Institute for Health Research (NIHR) Health Technology Assessment programme: £1,700,000
'Operative RIb Fixation Trial (ORIF)' Chief Investigator
2018-2022 Department of Defence Accelerator Grant STEMulate Study. £60,000 Co-Investigator
2019-2020 UK Innovate/EPSRC programme : £998,000 SMART Materials in Intramedullary Nailing Co-CI
2015-2020 NIHR Research for Patient Benefit (RfPB) Programme : £250,000 ANCHOR Study Chief Investigator
2020-2022 NIHR Doctoral Research Fellowship : £350,000 Lead Supervisor
2020-2022 National Institute for Health Research (NIHR) Health Technology Assessment programme: £1,020,000
'UK STAR' Co-applicant
2015-2020 ARUK Sports, Exercise and Arthritis Centre Awarded 2012 £17.6 million, renewed 2018 Co-Applicant